Colorectal cancer arises in individuals with acquired or inherited genetic predisposition who are exposed to a range of risk factors. Many of these risk factors are associated with affluent Western societies. More than 95% of colorectal cancers are sporadic, arising in individuals without a significant hereditary risk. Geographic variation in the incidence of colorectal cancer is considerable with a higher incidence observed in the West. Environmental factors contribute substantially to this variation. A number of these risk factors are associated with a Western lifestyle and could be considered a product of ‘civilization’. Recently, smoking has been recognized as a risk factor. Energy consumption also influences colorectal cancer risk, with obesity increasing risk and exercise reducing risk. However, the strongest contribution to environmental risk for colorectal cancer is dietary. Consumption of fat, alcohol and red meat is associated with an increased risk. Fresh fruit and vegetables and dietary fibre may be protective. Much has been learnt recently about the molecular pathogenesis of colorectal cancer. Colorectal cancer always arises in the context of genomic instability. There is inactivation of the tumour suppressor genes adenomatous polyposis coli, p53, transforming growth factor-β, activation of oncogene pathways including K-ras, and activation of the cyclooxygenase-2, epidermal growth factor receptor and vascular endothelial growth factor pathways. The mechanisms by which some environmental factors modify the mutation risk in these pathways have been described.

Keywords:
Civilization disorder, Colorectal cancer, geographical variations, Colorectal cancer incidence, Dietary changes, Lifestyle factors, Obesity, Physical activity, Smoking and alcohol
1.
Coleman MP, Quaresma M, Berrino F, Lutz JM, De AR, Capocaccia R, et al: Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730–756.
2.
GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates). Lyon, International Agency for Research on Cancer, 2005.
3.
Key TJ, Allen NE, Spencer EA, Travis RC: The effect of diet on risk of cancer. Lancet 2002;360:861–868.
4.
Popkin BM: The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 1994;52:285–298.
5.
Coyle YM: Lifestyle, genes, and cancer. Methods Mol Biol 2009;472:25–56:25–56.
6.
Flood DM, Weiss NS, Cook LS, Emerson JC, Schwartz SM, Potter JD: Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 2000;11:403–411.
7.
Colditz GA, DeJong W, Hunter DJ, Trichopoulos D, Willett WC: Harvard report on cancer prevention. Cancer Causes Control 1996;7(suppl):1–59.
8.
Vano YA, Rodrigues MJ, Schneider SM: Epidemiological link between eating habits and cancer: the example of colorectal cancer (in French). Bull Cancer 2009;96:647–658.
9.
Center MM, Jemal A, Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009;18:1688–1694.
10.
Matsushita Y, Takahashi Y, Mizoue T, Inoue M, Noda M, Tsugane S: Overweight and obesity trends among Japanese adults: a 10-year follow-up of the JPHC Study. Int J Obes (Lond) 2008;32:1861–1867.
11.
Kuriki K, Tajima K: The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pac J Cancer Prev 2006;7:495–501.
12.
Yang VW, Lewis J, Wang TC, Rustgi AK: Colon cancer: an update and future directions. Gastroenterology 2010;138:2027–2028.
13.
Pino MS, Chung DC: The chromosomal instability pathway in colon cancer. Gastroenterology 2010;138:2059–2072.
14.
Boland CR, Goel A: Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073–2087.
15.
Jass JR, Whitehall VLJ, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862–876.
16.
The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, WHO, 2002.
17.
Caperchione CM, Kolt GS, Mummery WK: Physical activity in culturally and linguistically diverse migrant groups to Western society: a review of barriers, enablers and experiences. Sports Med 2009;39:167–177.
18.
IARC Handbook of Cancer Prevention: Fruit and Vegetables. Lyon, International Agency for Research on Cancer, 2003, vol 8.
19.
Slattery ML: Physical activity and colorectal cancer. Sports Med 2004;34:239–252.
20.
Calton BA, Lacey J, Schatzkin A, Schairer C, Colbert LH, Albanes D, et al: Physical activity and the risk of colon cancer among women: a prospective cohort study (United States). Int J Cancer 2006;119:385–391.
21.
Larsson SC, Rutegård J, Bergkvist L, Wolk A: Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer 2006;42:2590–2597.
22.
Friedenreich C, Norat T, Steindorf K, Boutron-Ruault MC, Pischon T, Mazuir M, et al: Physical activity and risk of colon and rectal cancers: The European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2006;15:2398–2407.
23.
Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S: Physical activity and risk of colorectal cancer in Japanese men and women: the Japan Public Health Center-based prospective study. Cancer Causes Control 2007;18:199–209.
24.
Rosenberg L, Boggs D, Wise LA, Palmer JR, Roltsch MH, Makambi KH, et al: A follow-up study of physical activity and incidence of colorectal polyps in African-American women. Cancer Epidemiol Biomarkers Prev 2006;15:1438–1442.
25.
Quadrilatero J, Hoffman-Goetz L: Physical activity and colon cancer: a systematic review of potential mechanisms. J Sports Med Phys Fitness 2003;43:121–138.
26.
Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, et al: Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592–1600.
27.
Slattery ML, Anderson K, Curtin K, Khe-Ni M, Schaffer D, Edwards S, et al: Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001;483:73–81.
28.
Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, Anderson K, et al: Diet, activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 2002;11:541–548.
29.
James PT: Obesity: the worldwide epidemic. Clin Dermatol 2004;22:276–280.
30.
Zaninotto P, Wardle H, Stamatakis E, Mindell J, Head J: Forecasting Obesity to 2010. London, National Centre for Social Research/Department of Health, 2006.
31.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.
32.
Troiano RP, Flegal KM: Overweight prevalence among youth in the United States: why so many different numbers? Int J Obes Relat Metab Disord 1999;23(suppl 2)S22–S27.
33.
Boutron-Ruault MC, Senesse P, Méance S, Belghiti C, Faivre J: Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer 2001;39:50–57.
34.
Neugut AI, Lee WC, Garbowski GC, Waye JD, Forde KA, Treat MR, et al: Obesity and colorectal adenomatous polyps. J Natl Cancer Inst 1991;83:359–361.
35.
Lukanova A, Björ O, Kaaks R, Lenner P, Lindahl B, Hallmans G, et al: Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006;118:458–466.
36.
Bird CL, Frankl HD, Lee ER, Haile RW: Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 1998;147:670–680.
37.
Vainio H, Bianchini F: Weight Control and Physical Activity. IARC Handbook of Cancer Prevention. Lyon, International Agency for Research on Cancer, 2002, vol 6, pp 1–315.
38.
Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV: Obesity and gastrointestinal cancer. Br J Surg 2010;97:628–642.
39.
Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, et al: Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920–931.
40.
Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, et al: BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004;28:559–567.
41.
MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG: Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004;13:553–559.
42.
Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K: Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:385–391.
43.
Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F: Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 2001;10:937–941.
44.
Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, et al: A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006;164:652–664.
45.
Koenuma M, Yamori T, Tsuruo T: Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989;80:51–58.
46.
Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J: Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 1995;95:1897–1905.
47.
Giovannucci E: Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131(suppl):3109S–3120S.
48.
Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, et al: Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004;109:149–152.
49.
Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–783.
50.
Levy RL, Finch EA, Crowell MD, Talley NJ, Jeffery RW: Behavioral intervention for the treatment of obesity: strategies and effectiveness data. Am J Gastroenterol 2007;102:2314–2321.
51.
Lin OS: Acquired risk factors for colorectal cancer. Methods Mol Biol 2009;472:361–372.
52.
Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L, et al: Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 2001;93:525–533.
53.
Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN: Eating patterns and risk of colon cancer. Am J Epidemiol 1998;148:4–16.
54.
Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, Willett WC: Fruit and vegetable consumption and colorectal adenomas in the Nurses’ Health Study. Cancer Res 2006;66:3942–3953.
55.
Negri E, Franceschi S, Parpinel M, La Vecchia C: Fiber intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1998;7:667–671.
56.
Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, et al: Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003;361:1491–1495.
57.
Larsson SC, Giovannucci E, Bergkvist L, Wolk A: Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer 2005;92:1803–1807.
58.
Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, et al: Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003;361:1496–1501.
59.
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, et al: Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169–176.
60.
Asano T, McLeod RS: Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2002(2):CD003430.
61.
Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, Van Den Brandt PA, et al: Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005;294:2849–2857.
62.
Bingham SA: Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer. Proc Nutr Soc 1990;49:153–171.
63.
Bordonaro M, Lazarova DL, Sartorelli AC: Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 2008;7:1178–1183.
64.
Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, et al: Meat consumption and risk of colorectal cancer. JAMA 2005;293:172–182.
65.
Norat T, Lukanova A, Ferrari P, Riboli E: Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002;98:241–256.
66.
Cross AJ, Pollock JRA, Bingham SA: Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003;63:2358–2360.
67.
Sesink ALA, Termont DSM, Kleibeuker JH, Van Der Meer RD: Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res 1999;59:5704–5709.
68.
Hughes R, Cross AJ, Pollock JRA, Bingham S: Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 2001;22:199–202.
69.
Hughes R, Pollock JRA, Bingham S: Effect of vegetables, tea, and soy on endogenous N-nitrosation, fecal ammonia, and fecal water genotoxicity during a high red meat diet in humans. Nutr Cancer 2002;42:70–77.
70.
Scanlan RA: Formation and occurrence of nitrosamines in food. Cancer Res 1983;43 (suppl):2435s–2440s
71.
Hotchkiss JH: Preformed N-nitroso compounds in foods and beverages. Cancer Surveys 1989;8:295–321.
72.
Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682–4689.
73.
Miller JA: Research in chemical carcinogenesis with Elizabeth Miller – a trail of discovery with our associates. Drug Metab Rev 1994;26:1–36.
74.
Järvinen R, Knekt P, Hakulinen T, Rissanen H, Heliövaara M: Dietary fat, cholesterol and colorectal cancer in a prospective study. Br J Cancer 2001;85:357–361.
75.
Kato I, Tominaga S, Matsuura A, Yoshii Y, Shirai M, Kobayashi S: A comparative case-control study of colorectal cancer and adenoma. Jpn J Cancer Res 1990;81:1101–1108.
76.
Diergaarde B, Vrieling A, Van Kraats AA, van Muijen GN, Kok FJ, Kampman E: Cigarette smoking and genetic alterations in sporadic colon carcinomas. Carcinogenesis 2003;24:565–571.
77.
Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM: Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking. Am J Gastroenterol 2006;101:1313–1319.
78.
Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, et al: Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831–1836.
79.
Cho E, Smith-Warner SA, Ritz J, Van Den Brandt PA, Colditz GA, Folsom AR, et al: Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 2004;140:603–613.
80.
Harnack L, Jacobs J, Nicodemus K, Lazovich D, Anderson K, Folsom AR: Relationship of folate, vitamin B6, vitamin B12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 2002;43:152–158.
81.
Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al: Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993;85:875–884.
82.
Gellad ZF, Provenzale D: Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 2010;138:2177–2190.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.